Telangana Life Sciences

Sri K. Chandrashekar Rao

Hon’ble Chief Minister of Telangana State

Telangana has become the most favoured destination for both international and domestic investors. Under our industrial policy TS-iPASS, all approvals have to be given by Government within 15 days or it is deemed approved. Telangana State welcomes industrialists, investors and entrepreneurs. I promise you a graft-free and business friendly administration.

Sri K.T. Rama Rao

Hon’ble Minister for IT, Industries, MA & UD of Telangana State

Hyderabad, the capital city of Telangana, has a thriving Life Sciences Industry and the city is regarded as a leading lifesciences hotspot in Asia. We are proud of our achievements but not resting on our laurels, we have a vision to grow the industry from USD 50Bn to USD 100Bn and creating 400,000 new jobs in this decade.

KCR

KTR

Vision

To become the Leading life-sciences hub in Asia through innovation-driven & tech-enabled growth, while doubling the sectoral value to US$ 100 Billion and adding 400,000 new jobs by 2030

.

Hyderabad: Nucleus of Life Sciences in Asia

Contributes to 1/3rd of the global vaccine output

Only state in the world to have 200+ USFDA approved facilities

40% of total Indian API production and 50% of API exports

Accounts for more than 35% of India’s pharmaceutical production

Home to over 800 pharma and biotech companies with a valuation of over US$ 50 billion

20+ Lifesciences and MedTech Incubators in Hyderabad – Highest for any city in the Country

Clusters

Genome valley

India’s first and Largest Life Sciences manufacturing cluster
Asia’s leading R&D and Innovation Hotspot
4 out of 5 leading manufacturers of vacccine are present here and home to more than 200 companies

Medical Devices Park

India’s Largest medical devices park
Spread across 302 acres with dedicated ecosystem for MedTech innovation
Asia’s Largest coronary stent manufacturing facility

Hyderabad Pharma City

World’s Largest integrated pharma cluster
Regulatory enclave and Export promotion cell proposed as a part of the pharma city
Environmentally cleared cluster with investment potential of $9.7 Bn

Major players in Telangana

Gallery

Mr. Jayesh Ranjan, IAS

Principal Secretary,
Department of commerce & Industries
Govt. of Telangana.

Mr. Shakthi Nagappan

Director
(Life Sciences & Pharma) & CEO (Hyderabad Pharma City)
Govt. of Telangana.

Life Sciences Grid

Clusters

A cluster based model to “Work, Live, Learn & Play”, and Leveraging the social drivers to maximize economic growth

Global Companies

Telangana is home to over 800 Life Sciences companies with valuation of over USD 50 billion

Contract Research & Manufacturing Services

The state has best in class CRO providing services to pharmaceutical, biotechnology and medical devices in Country

Research and Development Institutes

Telangana is home to top R&D institutions such as Indian Institute of Chemical Technology. Institute of life Sciences, Center for Stem Cell Sciences

Academia

Telangana has over 4,500+ Engineering Colleges and 350+ Pharmacy Colleges

Skill Development

3,00,000+ students have been trained under the states flagship imitative TASK and over 2,50,000+ students graduate in various programmes in the state

Hyderabad Rated among Top 5 locations for R&D/ Product Engineering Talent in India

Hyderabad is home to World Class Talent for Research, Manufacturing and Innovation. More than 250,000 students in various graduation programs across 4,750 institutions.

It is also home to 30+ national research institutions.

Invest or Expand

Telangana has been consistently ranked among the top states in Ease of Doing Business (EoDB) Ranking conducted by the World Bank and Government of India.

Under our industrial policy, which makes time bound clearances within 15 / 30 days a RIGHT for the investor, has set new bench mark in transparency and efficiency and we have till date accorded approvals to over 14000 units, about 80% of which are already into commercial production. Also, life sciences sector in Telangana has attracted more than 700 new investments worth US$ 1.57 billion since 2015.